Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore the credit cards with the best rewards programs to maximize your benefits and savings. Find your perfect match.
26,855 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
As investors await a potential new federal reserve chair, analysts say the policy path could lift small-cap stocks. T...
As economists debate the timing of a downturn, real-time indicators suggest that the market moves first and the headl...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
States are racing to regulate home equity investment products as the market grows, with Maine enacting strict licensi...
Citi warns that the stock market frothiest since the global financial crisis has created vulnerabilities, but says pa...
Retail investors flock to a $50-priced ETF that looks like a safe cash substitute as rate expectations shift. Here’s ...
Strategy (formerly MicroStrategy) appears poised to complete its 100th Bitcoin purchase, signaling a bold continuatio...
Investors are turning to a Roth IRA strategy with GLDM to amplify a five-year gold rally. The move leverages tax-free...
The U.S. launched a new round of strikes against Iran, triggering swift market reactions and renewed concerns about a...
A legendary investor steps back, and a provocative figure—warren buffett's final $373—sparks fresh questions about ma...